INVESTMENT (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
|
| ILiAD Biotechnologies, LLC [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Aggregrate investment | $ 7,000,000 | $ 7,000,000 | |||
| Book value of the investment | $ 5,144,000 | $ 5,144,000 | |||
| Iliad [Member] | Class C Units [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Ownership percentage not fully diluted | 6.80% | 6.80% | |||
| Iliad [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Aggregrate investment | $ 7,000,000 | $ 7,000,000 | |||
| Equity investment net loss | 532,000 | $ 285,000 | 1,597,000 | $ 1,073,000 | |
| ILiAD additional comprehensive loss | $ 621,000 | ||||
| Allocated share of additional loss | $ 42,000 | $ 42,000 | |||
| Iliad [Member] | Class C Units [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Ownership percentage fully diluted | 6.10% | ||||